Deutsche Bank
TCRT icon

Deutsche Bank’s Alaunos Therapeutics TCRT Stock Holding History

Deutsche Bank’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3
Closed -$2K – 5094
2016
Q4 		$2K Buy
3
+1
+50% +$901 ﹤0.01% 4820
2016
Q3 		$1K Hold
2
– – ﹤0.01% 4860
2016
Q2 		$1K Sell
2
-5
-71% -$5.44K ﹤0.01% 5125
2016
Q1 		$8K Sell
7
-37
-84% -$37.9K ﹤0.01% 4872
2015
Q4 		$54K Buy
+44
New +$72.8K ﹤0.01% 4363
2015
Q3 		– Sell
-4
Closed -$6K – 5329
2015
Q2 		$6K Buy
+4
New +$6.21K ﹤0.01% 5125
2015
Q1 		– Sell
-5
Closed -$4K – 5887
2014
Q4 		$4K Sell
5
-20
-80% -$10.6K ﹤0.01% 5931
2014
Q3 		$9K Buy
25
+8
+47% +$3.86K ﹤0.01% 5423
2014
Q2 		$10K Buy
+17
New +$9.46K ﹤0.01% 5506

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Deutsche Bank's TCRT Position: Q2 2022 in Review

Deutsche Bank sold out of Alaunos Therapeutics (TCRT) in Q2 2022, closing a stake of 810 shares — an estimated $79K sold.

Deutsche Bank first reported a position in TCRT in Q2 2013 and held it in 36 quarters. The position peaked at $3.98M in Q3 2016. 124 funds tracked by Wall St. Rank hold TCRT as of Q2 2022.

  • Deutsche Bank reported no remaining Alaunos Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 810 Alaunos Therapeutics shares in Q2 2022, an estimated $79K.
  • Deutsche Bank first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 36 quarters.
  • Deutsche Bank's Alaunos Therapeutics position peaked at $3.98M in Q3 2016.
  • 124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.